ScienceGeist

How, then, does an agency like NSF—which has considerable influence but limited direct authority—work with the community and other institutions to implement change on issues that cannot wait? The case of NSF's work to combat harassment in the science community, a persistent problem for decades that remains shockingly widespread, is illustrative.

Despite the limitations of funding acknowledgment (FA) data in Web of Science (WoS), studies using FA information have increased rapidly over the last several years. Considering this WoS' recent practice of updating funding data, this paper further investigates the characteristics and distribution of FA data in four WoS journal citation indexes.

The National Science Foundation is testing a creative mix of machine learning, blockchain technology and data science to tackle a stubborn challenge: How to better evaluate more than 60,000 grant applications it receives each year.

Research charities Wellcome Trust and the Gates Foundation announced they are joining forces with the credit card company MasterCard in a $125 million push to speed up development of drugs for treating COVID-19 infections, in the latest example of the rush to fund research into the novel coronavirus.

New OA payment models are needed make open access implementation practical, journal editor says.

A researcher from the Wuhan University of China offers a view of how Chinese researchers are reacting and are likely to alter their behavior in response to new policies governing research evaluation.

Three searchable databases provide information on global opportunities for graduate students, postdocs and junior faculty members.

This article argues it is irresponsible to support research but not data stewardship.

Failed funding applications are inevitable, but perseverance can pay dividends.

Academic scientists and research institutes are increasingly being evaluated using digital metrics, from bibliometrics to patent counts. These metrics are often framed, by science policy analysts, economists of science as well as funding agencies, as objective and universal proxies for scientific worth, potential, and productivity.

Emmanuel Macron has urged EU member states to put more money into the collective Brussels pot so Europe can invest in key technologies of the future. The French president said he is "not frustrated but impatient" for the EU to take on bigger projects.

A survey of New Zealand scientists found that recipients of a randomized funding program favored random allocations of some kinds of grant money.

White House proposes big cuts to NIH, DOE, NASA and other programs

This article elaborates on the role of research funding organizations in developing a FAIR funding model to support the FAIR research data management in the funding cycle.

Up to £200,000 per society available for flagging important biomedical research outputs.

Promises to double funding and create new blue skies research agency sit uneasily with likelihood of crashing out of EU science programmes.

The United States is no longer the 'uncontested leader' in science globally, the National Science Foundation says.

Balancing Dominic Cummings' agenda with industrial strategy approach, and deciding on geographical focus for increased investment, seen as key challenges

How will climate change shape the Earth's surface? What are the long-term health effects of food additives? How can online tools change political advocacy and what does this mean for democracy? These are just some of the questions that researchers from around Europe have proposed to explore, and will now be able to, thanks to newly-awarded EU funding.

Predict, a government research program, sought to identify animal viruses that might infect humans and to head off new pandemics. Now the program has been cancelled.

A recent study finds a strong correlation between university revenues and their volume of publications and (field-normalized) citations. These results demonstrate empirically that international rankings are by and large richness measures and, therefore, can be interpreted only by introducing a measure of resources.

Background Core outcome sets (COS) have the potential to reduce waste in research by improving the consistency of outcomes measured in trials of the same health condition. However, this reduction in waste will only be realised through the uptake of COS by clinical trialists. Without uptake, the continued development of COS that are not implemented may add to waste in research. Funders of clinical trials have the potential to have an impact on COS uptake by recommending their use to those applying for funding. The aim of our study was to assess the extent to which applicants followed the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme's recommendation to search for a COS to include in their clinical trial. Methods and findings We examined the outcomes section and detailed project descriptions of all 95 researcher-led primary research applications submitted to the NIHR HTA between January 2012, when the recommendation to search for a COS was included in the guidance for applicants, and December 2015 for evidence that a search for a COS had taken place and rationale for outcome choice in the absence of COS. A survey of applicants was conducted to further explore their use of COS and choice of outcomes with a response rate of 49%. Nine out of 95 applicants (10%) stated in their application that they had searched the COMET (Core Outcome Measures for Effectiveness Trials) Initiative database for a COS and another nine referred to searching for a COS using another method, e.g. a review of the literature. Of the 77 (81%) applicants that did not mention COMET or COS in their application, eight stated in the survey that they had searched the COMET database and ten carried out a search using another method. Some applicants who did not search for a COS gave reasons for their choice of outcomes including taking advice from patients and the public and choosing outcomes used in previous trials. Conclusion A funding body can have an impact on COS uptake by encouraging trialists to search for a COS. Funders could take further steps by putting processes in place to prompt applicants to be explicit about searching for COS in their application and notifying the funding board if a search has not taken place. The sources of information used by trialists to make decisions about outcomes in the absence of COS may suggest methods of dissemination for COS.

The UK's share of EU research funding has fallen dramatically because of Brexit uncertainty, with the country's take home from the EU Horizon 2020 programme cut by almost €500 million since 2015, according an analysis by the Royal Society.

Peer review process helps funders make decisions, but researchers say it is lacks transparency and takes up too much of their time.

A Publons study aiming to bridge the gap in data and insights into the peer review of research funding and grant applications.

A new report summarises the results of a survey of European research funders on Open Access and Research Data policies, commissioned by SPARC Europe.

The pursuit of money from wealthy donors distorts the research process-and yields flashy projects that don't help and don't work.

Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined cancer research funding from nonprofit organizations.